Sen. Thomas R. Carper bought Tekla Life Sciences Investors (HQL)
Sen. Thomas R. Carper (D-DE) · $1K–$15K · traded Feb 22, 2020
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Feb 22, 2020
- Disclosed
- Mar 3, 2020
- Days to disclose
- 10
- Asset type
- Stock
- As filed
- Tekla Life Sciences Investors
- Industry
- Asset Management · Financial Services
Other trades in this filing
DisclosedTradeAmount
- Mar 3, 2020$1K–$15K
Sold (full) BlackRock Science and Technology Trust II BSTZ
$1K–$15K · Traded Feb 22, 2020 · disclosed Mar 3, 2020 · Spouse
- Mar 3, 2020$15K–$50K
Bought HSBC Contingent Autocall BMY Rate/Coupon: 8.75% Matures: 02/24/2023
$15K–$50K · Traded Feb 21, 2020 · disclosed Mar 3, 2020 · Spouse
- Mar 3, 2020$15K–$50K
Sold (full) BCS Contingent Autocall BMY Rate/Coupon: 9.0% Matures: 11/14/2022
$15K–$50K · Traded Feb 13, 2020 · disclosed Mar 3, 2020 · Spouse
Recent Congress trades in HQL
DisclosedTradeAmount
- Nov 3, 2022$1K–$15K
Sen. Thomas R. Carper (D-DE)
Sold (full) Tekla Life Sciences Investors HQL
$1K–$15K · Traded Oct 4, 2022 · disclosed Nov 3, 2022 · Spouse
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.